Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Breaking News

Breaking News

Apr 07, 2020

United Global Alliance to Distribute Acumen Research Labs Coronavirus Test Kit

United said it will distribute the test to international governments and healthcare organizations.

Apr 07, 2020

NanoString Preliminary Q1 Revenues Take Hit From COVID-19, Firm Withdraws 2020 Guidance

The company said its product and services revenues were about $24.5 million for the quarter, 15 percent higher than the same period last year.

Apr 07, 2020

Bioneer Inks Deal With Qatar Petroleum to Supply Coronavirus Test Kits, Instruments

Under the agreement, Bioneer will supply instruments, nucleic acid extraction reagents, and COVID-19 test kits, which will be placed at medical institutions in Qatar.

Apr 07, 2020

FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

The assay is a real-time RT-PCR test designed for the qualitative detection of specific sequences of the SARS-CoV-2 N gene in respiratory specimens.

Apr 07, 2020

Tauriga Sciences, Aegea Biotechnologies Ink Development Deal for SARS-CoV-2 Test

The multiplexed PCR-based test will use Aegea's technology to measure the virus from nasal or other swabs, even in asymptomatic patients.

Apr 07, 2020

Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

The company said that its preliminary revenues are expected to be down almost 8 percent year over year due to the pandemic.

Apr 07, 2020

FDA Issues Emergency Use Authorization for Gnomegen Coronavirus Test

The PCR-based test is designed to detect the nucleocapsid gene of the SARS-CoV-2 virus in nasal, nasopharyngeal, and oropharyngeal swab specimens.

Apr 06, 2020

Luminex Preliminary Q1 Revenues Rise 10 Percent

Luminex said that its Q1 molecular diagnostics revenues are anticipated to rise more than 25 percent year over year, driven by SARS-CoV-2 test sales.

Apr 06, 2020

BGI, Aid Genomics Partner to Build COVID-19 Testing Lab in Gaza

Both the Israeli and Palestinian authorities have granted approval for the lab to perform 3,000 COVID-19 tests per day for Gaza residents.

Apr 06, 2020

Coriell Institute Awarded $9.2M to Continue Operating NIGMS Biobank

The NIGMS repository holds and distributes over 11,700 unique cell lines, as well as more than 6,300 DNA samples, representing over 1,000 heritable diseases.

Apr 06, 2020

Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

The three hospital laboratories' tests are all real-time PCR assays for detecting the virus from nasopharyngeal swabs and bronchoalveolar lavage.

Apr 06, 2020

Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery

Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines.

Apr 06, 2020

Top Five Articles on GenomeWeb Last Week: FDA, Qiagen, Color, and More

Last week, GenomeWeb's readers were most interested in new EUA guidance from the FDA for molecular-based laboratory developed tests detecting SARS-CoV-2.

Apr 06, 2020

Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

The company said that as the COVID-19 pandemic spread throughout the world, it saw a "significant reduction in customer activity" by late March.

Apr 06, 2020

Luminex Receives FDA Emergency Use Authorization for Second SARS-CoV-2 Assay

Luminex said that with two FDA EUAs it is now providing SARS-CoV-2 diagnostic tests for high-complexity, high-throughput labs and moderate-complexity testing facilities.

Apr 06, 2020

ScienCell SARS-CoV-2 Test Gets FDA Emergency Use Authorization

The test is a real-time RT-PCR kit designed to detect SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs, as well as bronchoalveolar lavage.

Apr 06, 2020

Co-Diagnostics Gets FDA Emergency Use Authorization for Coronavirus Test

The PCR-based test, which recently received CE-IVD marking, uses Co-Diagnostics' CoPrimer technology to detect the RdRp gene of the SARS-CoV-2 virus.

Apr 06, 2020

Myriad Genetics BRCA Test to be Reimbursed in Japan

The diagnostic will be covered when patients are tested according to the Japanese Organization of Hereditary Breast and Ovarian Cancer's criteria.

Apr 03, 2020

With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

MicroGen Dx's Texas-based lab is the only commercial laboratory in the US offering sputum testing for SARS-CoV-2.

Apr 03, 2020

Partial Polygenic Scores Improve Phenotypic Predictions in Recently Admixed Individuals

The approach deconvolutes admixed individuals' ancestries and develops polygenic risk scores based on each component that can then be combined.

Apr 03, 2020

LexaGene Shifts Gears to Prepare Viral RT-qPCR Panel for FDA Emergency Submission

After validating its pathogen detection platform for multiple viruses, the firm aims to initially offer a point-of-care diagnostic testing panel by the third quarter.

Apr 03, 2020

People in the News: Kim Popovits, Miles Harrison, Matt Sargent, More

Apr 03, 2020

In Brief This Week: BGI, Novacyt, Promega, and More

News items for the week of March 30, 2020.

Apr 03, 2020

New Products Posted to GenomeWeb: SensID, Thermo Fisher Scientific, Enpicom, More

Apr 03, 2020

Breast Cancer Subtypes Vary With Indigenous Ancestry in Latin American Women

Women with breast cancer from Peru, Mexico, or Colombia who had greater Indigenous American ancestry were more likely to have HER2-positive tumors.

Pages

The Scan

Another Paper Gone

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational Biologist James Taylor Dies

Computational biologist James Taylor has died, according to Johns Hopkins University.

Ever Infected

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

PLOS Papers on Hepatocellular Carcinoma Immune Cells, Regulatory Prostate Cancer Risk SNPs, More

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.

What's Popular?

  1. Luminex Receives FDA Emergency Use Authorization for Second SARS-CoV-2 Assay

  2. Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

  3. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

  4. Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

  5. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.